Back to results
CompletedPhase 1

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

NCT00495417

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Department of Clinical Pharmacology, Medical University of Vienna

Vienna, Austria

View on ClinicalTrials.gov
Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease — TrialFind